PhilClapharma
Timeline
16 events since 2017Board
Filings
Financial
Establishments
20182020202220242026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBmicro format · 32 days before the deadline
2025
Weakest financial year net €18,464 ▼50% The net result drops to €18,464, the lowest from 2018 to 2025.
Registered in the Peppol Directory Reachable for e-invoices through 0208:0675782469
Annual accounts 2024 filed PDFmicro format · 33 days before the deadline
2024
Annual accounts 2023 filed PDFmicro format · 37 days before the deadline
Change of role: DERVEAUX Emmanuelle Marie Philippe Clara, from manager to directorGeneral meeting of 30-12-20234 points ▸
- General meeting, 30-12-2023
- Director resignation, DERVEAUX Emmanuelle Marie Philippe Clara (manager)
- Director appointment, DERVEAUX Emmanuelle Marie Philippe Clara (director (not named in the articles))
- Registered office clause, Brusselsesteenweg 77, 3080 Tervuren
- The deed holds 6 more points.
2023
Annual accounts 2022 filed PDFmicro format · 28 days late
2022
Equity above €200,000 equity €234,484 ▲21.4% With a profit in every financial year since 2018, equity grows to €234,484.
Annual accounts 2021 filed PDFmicro format · 18 days before the deadline
2021
Annual accounts 2020 filed PDFmicro format · 17 days before the deadline
2020
Equity above €150,000 equity €151,890 ▲31.8% With a profit in every financial year since 2018, equity grows to €151,890.
Annual accounts 2019 filed PDFmicro format · 7 days before the deadline
2019
Equity above €100,000 equity €115,258 ▲37.7% With a profit in every financial year since 2018, equity grows to €115,258.
Annual accounts 2018 filed PDFmicro format · 29 days late
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank